American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting - Results from #40

Viewing 41-54 of 54 articles

ASTRO 2022: The Proportion of Prostate Cancer Randomized Control Trials Involving Radiation Therapy over Time

ASTRO 2022: PSMA PET/CT–Based Atlas for Prostatic Bed Recurrence of Prostate Cancer after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy

ASTRO 2022: Impact of PSMA PET/CT on Prostate Cancer Salvage Radiotherapy Management: Results from the Prospective Randomized Phase 3 Trial PSMA SRT

ASTRO 2022: Treatment of Local Regional Disease in the Era of PSMA PET

ASTRO 2022: Approach to Prostate Oligometastasis in the PSMA PET/CT Era

ASTRO 2022: PSMA PET Staging: Does This Change Everything?

ASTRO 2022: The State of the Art in Digital Pathology and AI: Progress in Prostate Cancer

ASTRO 2022: Clinical Integration of Machine Learning for Curative-Intent Radiation Treatment of Patients with Prostate Cancer

ASTRO 2022: Abdominal Aorto-Iliac Calcification Burden Assessment Using Deep Convolutional Neural Networks for Prediction of Cardiovascular Risk Among Prostate Cancer Patients Undergoing Stereotactic Body Radiotherapy

ASTRO 2022: Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate

ASTRO 2022: Conditional Survival Probabilities in Recurrent Prostate Cancer Patients Receiving Radiation ± Antiandrogen Therapy: Secondary Analysis of a Randomized Clinical Trial

ASTRO 2022: Conditional Survival of Patients with Prostate Cancer Undergoing External-Beam Radiotherapy on RTOG 0126 and 0415

ASTRO 2022: PSMA PET Response Associates with Metastasis-Free Survival Following Stereotactic Ablative Radiation Therapy in Oligometastatic Castration-Sensitive Prostate Cancer

ASTRO 2022: Tertiary Gleason Pattern 5 and a High Genomic Classifier Score Better Predicts Lymph Node Invasion at Radical Prostatectomy in 20,441 Intermediate-Risk Disease Patients

1
2
3

email news signup